Expression of cell cycle proteins in head and neck cancer correlates with tumor site rather than tobacco use
- 8 August 2002
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 38 (6) , 618-623
- https://doi.org/10.1016/s1368-8375(01)00108-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survivalInternational Journal of Cancer, 2000
- Head and Neck Cancer in CNonsmokers: A Distinct Clinical and Molecular EntityThe Laryngoscope, 1999
- Human Papillomavirus in Head and Neck Squamous Cell Carcinomas in NonsmokersJAMA Otolaryngology–Head & Neck Surgery, 1997
- Clinical and molecular aspects of squamous cell carcinoma of the head and neck in the nonsmoker and nondrinkerCurrent Opinion in Oncology, 1997
- Squamous Cell Head and Neck Cancer in NonsmokersAmerican Journal of Clinical Oncology, 1997
- Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16Nature, 1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Cyclin D1 is a nuclear protein required for cell cycle progression in G1.Genes & Development, 1993
- Head and Neck CancerNew England Journal of Medicine, 1993
- Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neckBritish Journal of Cancer, 1991